SLAM Family Member 6 (SLAMF6) Peptid
SLAMF6
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
Produktnummer ABIN937856
382,12 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach:
Deutschland
Lieferung in 20 bis 27 Werktagen
Kurzübersicht für SLAM Family Member 6 (SLAMF6) Peptid (ABIN937856)
Target
SLAMF6
(SLAM Family Member 6 (SLAMF6))
Spezies
Säugetier
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Protein-Typ
- Synthetic
-
Sequenz
- EIHVTNPKQG KRLNFTQSYS LQLSNLKMED TGSYRAQIST KTSAKLSSYT
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of SLAMF6 antibody,
Alternative Names: SLAMF6 control peptide, SLAMF6 antibody Blocking Peptide, Anti-SLAMF6 Blocking Peptide, Slam Family Member 6 Blocking Peptide, KALI Blocking Peptide, KALIb Blocking Peptide, Ly108 Blocking Peptide, MGC104953 Blocking Peptide, NTB-A Blocking Peptide, NTBA Blocking Peptide, SF2000 Blocking Peptide, SLAMF6, SLAMF-6, SLAMF 6, SLAMF-6 Blocking Peptide, SLAMF 6 Blocking Peptide
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- SLAMF6 (SLAM Family Member 6 (SLAMF6))
-
Hintergrund
- SLAMF6 is a type I transmembrane protein, belonging to the CD2 subfamily of the immunoglobulin superfamily. SLAMF6 is expressed on Natural killer (NK), T, and B lymphocytes. It undergoes tyrosine phosphorylation and associates with the Src homology 2 domain-containing protein (SH2D1A) as well as with SH2 domain-containing phosphatases (SHPs). It may function as a coreceptor in the process of NK cell activation. It can also mediate inhibitory signals in NK cells from X-linked lymphoproliferative patients.
-
Molekulargewicht
- 34 kDa
Target
-
Sie sind hier:
